Also known as: Zantac; Ranitidine HCl; Tritec
Ranitidine is a pharmaceutical-grade active ingredient classified as an H₂ Receptor Antagonist Antiulcer agent. Mediocon Inc supplies high-purity Ranitidine API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.
Ranitidine is an H2-receptor antagonist that competitively inhibits histamine at the H2 receptors of gastric parietal cells, reducing basal and stimulated acid secretion. It is used in the treatment of peptic ulcers, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. Ranitidine HCl is the pharmaceutical salt form widely used in tablet and injection formulations.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Ranitidine (CAS 66357-35-5) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Ranitidine is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance